Cumberland Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +160.3% | +9.2% | +7.6% | +233.3% | -11.3% | +3.8% | +3.2% | -11.1% | +8.9% | -3.7% | +1.6% | -0.2% | +20.9% | -7.2% | -7.7% | -12.4% | +10.0% | -12.0% | -7.6% | +1.6% | |
| – | +47.2% | +17.0% | +19.8% | +426.1% | -13.0% | +7.7% | -0.1% | -21.3% | +3.1% | -5.2% | -2.3% | +4.8% | +9.0% | -33.0% | -0.4% | -8.6% | +0.4% | -22.1% | +2.1% | +1.7% | |
| – | +13.0% | +72.9% | +9.4% | +565.3% | -16.3% | +7.1% | -23.0% | -24.8% | -2.5% | -4.2% | -9.7% | +31.6% | -38.5% | +1.0% | -12.3% | +9.2% | -26.9% | -7.3% | -2.0% | -36.3% | |
| – | +13.0% | +72.9% | +9.4% | +565.3% | -16.3% | +7.1% | +0.6% | -22.7% | -0.3% | -3.5% | -5.0% | -0.1% | -27.7% | -22.1% | -12.3% | +9.2% | -26.9% | -7.3% | -2.0% | -36.3% | |
| – | +112.0% | -53.6% | +31.8% | +97.4% | -16.7% | +37.7% | -15.0% | -24.7% | +21.5% | +10.4% | +20.6% | +14.5% | -6.6% | +0.2% | +57.5% | -44.4% | +91.4% | -25.9% | +19.9% | +44.8% | |
| – | +22.8% | +41.4% | +85.7% | +173.6% | +59.3% | -24.8% | +7.7% | -8.0% | -2.1% | -23.8% | +25.8% | +25.4% | +313.0% | -68.1% | +19.9% | -20.8% | +17.0% | -53.3% | -13.2% | +55.6% | |
| – | – | – | -6.1% | +112.5% | +32.9% | -8.3% | +6.2% | -25.9% | -26.1% | -17.6% | -13.4% | +13.9% | +45.8% | +2,013.9% | -25.0% | -88.0% | +275.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +12.5% | +0.0% | +0.0% | +3.6% | +0.0% | +0.0% | +0.0% | |
| – | +26,497.1% | -6.9% | -6.8% | -6.7% | -6.6% | +1,316,758.3% | -100.0% | +63.5% | +39.2% | -1.9% | +4.7% | -3.2% | +56.9% | -8.1% | -9.1% | -14.8% | +27.7% | -26.1% | -20.5% | -22.0% | |
| – | +289.8% | -20.7% | +11.4% | +132.2% | -54.5% | -11.5% | +2.7% | -36.1% | +76.1% | +3.0% | +34.3% | +44.5% | +94.9% | -6.4% | -7.2% | -15.6% | +36.1% | -7.8% | +1.0% | -1.4% | |
| – | +194.8% | -6.7% | -6.3% | +144.9% | -50.5% | -28.5% | +22.1% | -6.3% | +82.2% | -9.7% | +19.2% | +19.6% | +57.1% | -13.1% | +6.3% | -24.9% | +48.2% | -2.1% | +13.0% | +16.2% | |
| – | +551.9% | +72.3% | -60.4% | +636.5% | -71.0% | – | – | – | – | – | +141.2% | +139.0% | – | – | +248.1% | -69.7% | -82.2% | +101.3% | +1,467.5% | -91.4% | |
| – | +240.7% | -43.0% | +69.5% | +72.9% | -62.3% | -28.8% | +84.4% | -27.0% | +59.3% | -11.3% | +179.3% | +11.7% | +23.5% | -9.9% | +34.0% | -28.0% | +12.2% | +29.7% | -0.9% | +33.4% | |
| – | – | – | +508.1% | +93.0% | -58.3% | +8.2% | -10.3% | -100.0% | – | – | +141.2% | +139.0% | +104.1% | -7.5% | -18.9% | +0.0% | +8.0% | -21.1% | -20.4% | -48.5% | |
| – | +78.5% | +50.5% | +4.8% | +311.6% | +7.6% | +6.6% | +3.3% | -7.3% | +1.6% | -4.9% | -4.8% | -12.6% | -12.6% | -8.5% | -8.1% | -8.9% | -15.3% | -18.4% | -22.8% | +8.9% | |
| – | – | – | – | +213.1% | +54.1% | +80.8% | +46.2% | -11.4% | +14.8% | +3.9% | -4.8% | -37.1% | -59.5% | -74.5% | -276.4% | – | – | – | – | – | |
| – | +2.3% | +0.8% | -0.3% | +10.2% | +15.5% | -2.3% | -3.8% | -7.4% | -2.4% | -4.5% | -5.0% | -2.0% | -1.9% | -1.4% | -1.5% | -1.7% | -2.3% | -1.8% | -1.7% | +6.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.